Enhancing Telemedicine for T2D

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 3, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

July 30, 2026

Conditions
Type 2 Diabetes
Interventions
OTHER

Enhanced Telemedicine for Type 2 Diabetes

Telemedicine-based endocrinology specialty care for type 2 diabetes with multidisciplinary diabetes care team support including pre-visit preparation, in-visit support and self-management education, and post-visit follow-up.

OTHER

Usual Telemedicine Endocrinology Care for T2D

Routine telemedicine-based endocrinology specialty care for type 2 diabetes, generally consisting of synchronous virtual visit with an endocrinologist and additional support including self-management education on an individualized basis.

Trial Locations (1)

15213

RECRUITING

University of Pittsburgh, Pittsburgh

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Pittsburgh

OTHER